GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » Beneish M-Score

Gaush Meditech (HKSE:02407) Beneish M-Score : -2.58 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.58 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Gaush Meditech's Beneish M-Score or its related term are showing as below:

HKSE:02407' s Beneish M-Score Range Over the Past 10 Years
Min: -3.3   Med: -3.27   Max: -2.58
Current: -2.58

During the past 5 years, the highest Beneish M-Score of Gaush Meditech was -2.58. The lowest was -3.30. And the median was -3.27.


Gaush Meditech Beneish M-Score Historical Data

The historical data trend for Gaush Meditech's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech Beneish M-Score Chart

Gaush Meditech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - -3.30 -3.27 -2.58

Gaush Meditech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial -3.30 - -3.27 - -2.58

Competitive Comparison of Gaush Meditech's Beneish M-Score

For the Medical Devices subindustry, Gaush Meditech's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gaush Meditech's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Gaush Meditech's Beneish M-Score falls into.



Gaush Meditech Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Gaush Meditech for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8923+0.528 * 1.0141+0.404 * 1.0025+0.892 * 1.0986+0.115 * 0.9084
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0098+4.679 * -0.026555-0.327 * 0.887
=-2.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$242.0 Mil.
Revenue was HK$1,538.1 Mil.
Gross Profit was HK$756.5 Mil.
Total Current Assets was HK$1,521.3 Mil.
Total Assets was HK$3,110.4 Mil.
Property, Plant and Equipment(Net PPE) was HK$137.9 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$83.1 Mil.
Selling, General, & Admin. Expense(SGA) was HK$413.7 Mil.
Total Current Liabilities was HK$975.3 Mil.
Long-Term Debt & Capital Lease Obligation was HK$138.7 Mil.
Net Income was HK$189.8 Mil.
Gross Profit was HK$0.0 Mil.
Cash Flow from Operations was HK$272.4 Mil.
Total Receivables was HK$246.9 Mil.
Revenue was HK$1,400.1 Mil.
Gross Profit was HK$698.3 Mil.
Total Current Assets was HK$1,481.1 Mil.
Total Assets was HK$3,035.3 Mil.
Property, Plant and Equipment(Net PPE) was HK$141.5 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$73.4 Mil.
Selling, General, & Admin. Expense(SGA) was HK$372.9 Mil.
Total Current Liabilities was HK$550.1 Mil.
Long-Term Debt & Capital Lease Obligation was HK$675.5 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(242.028 / 1538.113) / (246.913 / 1400.12)
=0.157354 / 0.176351
=0.8923

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(698.324 / 1400.12) / (756.457 / 1538.113)
=0.49876 / 0.491808
=1.0141

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1521.267 + 137.898) / 3110.398) / (1 - (1481.137 + 141.548) / 3035.331)
=0.466575 / 0.465401
=1.0025

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1538.113 / 1400.12
=1.0986

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(73.422 / (73.422 + 141.548)) / (83.091 / (83.091 + 137.898))
=0.341545 / 0.375996
=0.9084

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(413.68 / 1538.113) / (372.91 / 1400.12)
=0.268953 / 0.266341
=1.0098

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((138.662 + 975.287) / 3110.398) / ((675.486 + 550.119) / 3035.331)
=0.358137 / 0.40378
=0.887

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(189.796 - 0 - 272.393) / 3110.398
=-0.026555

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Gaush Meditech has a M-score of -2.58 suggests that the company is unlikely to be a manipulator.


Gaush Meditech Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Gaush Meditech (HKSE:02407) Business Description

Traded in Other Exchanges
Address
No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.
Executives
Orbimed Advisors Iii Limited 2102 Investment manager
Orbimed Asia Gp Iii, L.p. 2102 Investment manager
Orbimed Asia Partners Iii, L.p. 2102 Investment manager
Gao Tieta 2201 Interest of corporation controlled by you
Gaush Holding Ltd 2101 Beneficial owner
Cuprite Gem Investments Ltd 2101 Beneficial owner
Warburg Pincus (bermuda) Private Equity Gp Ltd. 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp Llc 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp, L.p. 2201 Interest of corporation controlled by you
Warburg Pincus China-southeast Asia Ii (cayman), L.p. 2201 Interest of corporation controlled by you
Warburg Pincus Partners Ii (cayman), L.p. 2201 Interest of corporation controlled by you

Gaush Meditech (HKSE:02407) Headlines

No Headlines